development, molecular diagnostics or clinical trials.

The innovative offerings from Randox Biosciences are focused around our revolutionary multiplex Biochip Array Technology which includes multiplex protein immunoassays and multiplex nucleic acid arrays, delivered via the Evidence range of analysers.

Randox Biosciences’ range of molecular products offers diagnostic, prognostic and predictive solutions across a variety of disease areas including sexually transmitted infection, cardiovascular disease (CVD), familial hypercholesterolemia (FH), colorectal cancer and respiratory infection.

Randox’s core product lines of clinical chemistry reagents, quality controls and proficiency testing remain essential offerings for Randox Biosciences as these products are widely utilised in the world’s leading academic research centres, pharmaceutical companies and contract research organisations.

Randox Biosciences’ also specialises in the manufacture of a range of high quality monoclonal & polyclonal antibodies, antibody fragments, human recombinant proteins and conjugates for research and also supplies these to other diagnostic companies further enabling healthcare innovation.

Companion diagnostics are the latest development with Randox Biosciences engaging with large pharma clients enabling drug development and regulatory approval, with the potential to transform healthcare across a range of therapeutic areas.